a month ago
ARGX
AnalystsAllison BratzelAllison Bratzel's Stock Forecasts
AnalystsAllison Bratzel
Sectors:
Industries:
Analyst Ranking
Top 17%
#811 out of 4753 analysts
Average Return
+23.96%
Win Rate
71%17 out of 24
Risk vs Reward
Poor
Good
Allison Bratzel's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Scholar Rock Holding CorpSRRK | +153.07% | $15.00 | $37.96 | 2024-03-25 - 2024-12-02 | Strong Buy |
Scholar Rock Holding CorpSRRK | +86.26% | $8.44 | $15.72 | 2023-04-02 - 2024-04-02 | Strong Buy |
Vectivbio Holding AgVECT | +77.37% | $9.50 | $16.85 | 2023-04-19 - 2023-07-07 | Strong Buy |
Argenx SeARGX | +74.37% | $354.13 | $617.49 | 2023-12-20 - 2024-12-02 | Strong Buy |
Argenx SeARGX | +68.81% | $365.78 | $617.49 | 2024-01-17 - 2024-12-02 | Strong Buy |
Allison Bratzel Analyst Color
Get additional color on Allison Bratzel's coverage of popular stocks
2 months ago
SRRK
5 months ago
ROIV
a year ago
ARGX
Allison Bratzel's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Travere Therapeutics IncTVTX | 2 | Hold | $22.00 | +12.42% | Maintains | 19 days ago |
Rigel Pharmaceuticals IncRIGL | 2 | Hold | $23.00 | -14.97% | Maintains | 19 days ago |
Ionis Pharmaceuticals IncIONS | 1 | Strong Buy | $62.00 | +71.75% | Maintains | 19 days ago |
Argenx SeARGX | 12 | Strong Buy | $620.00 | +0.41% | Maintains | a month ago |
Scholar Rock Holding CorpSRRK | 3 | Strong Buy | $42.00 | +10.64% | Maintains | 2 months ago |
Roivant Sciences LtdROIV | 2 | Strong Buy | $22.00 | +76.28% | Maintains | 5 months ago |
Humacyte IncHUMA | 2 | Hold | $4.00 | -10.11% | Maintains | 8 months ago |
Solid Biosciences IncSLDB | 4 | Strong Buy | $20.00 | +245.42% | Upgrades | 9 months ago |
Abcellera Biologics IncABCL | 1 | Strong Buy | $20.00 | N/A | Assumes | a year ago |
Vectivbio Holding AgVECT | 1 | Strong Buy | $25.00 | N/A | Maintains | 2 years ago |
Replimune Group IncREPL | 1 | Strong Buy | $44.00 | N/A | Assumes | 2 years ago |
Incyte CorpINCY | 2 | Strong Buy | $100.00 | N/A | Maintains | 2 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.